SAB Biotherapeutics, Inc.

Ownership Transactions Reported by 29 Insiders

Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
777 W 41 St St, Suite 401, Miami Beach, FL

There are no Buy or Sell transactions made by insiders since 12/2/2024

SAB Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Edward D. Hamilton 10%+ Owner $9.32M Oct 22, 2021
Andrew Moin Director $3.85M Sep 29, 2025
Sessa Capital (Master), L.P. Director $3.85M Sep 29, 2025
Ilan Katz Director, 10%+ Owner $2.68M Oct 13, 2021
Helen K. Ellias Director $2.51M Nov 1, 2024
Alexandra Kropotova Chief Medical Officer $95.1K Sep 19, 2025
Frederick Finnegan Chief Business Officer $52.8K Mar 16, 2022
Thomas Charles Luke Chief Medical Officer $7.42K Mar 16, 2022
Michael King Chief Financial Officer $4.4K Feb 21, 2024
Samuel J. Reich CEO & EXECUTIVE CHAIRMAN, Director Aug 26, 2025
Christoph Bausch Chief Operating Officer Aug 26, 2025
Mark Conley Interim Chief Financial Officer, Vice President of Finance Jun 4, 2024
William James Polvino Director Jul 15, 2024
Bruce Kipp Erickson Chief Operating Officer Mar 16, 2022
Charles Hiram Randall Chief Strategy Officer Oct 22, 2021
Carlos N. Carillo SVP Regulatory Affairs Oct 22, 2021
Erick Lucera Director Jul 15, 2024
E. Hamilton Director Jul 15, 2024
Jeffrey G. Spragens Director Jul 15, 2024
Mervyn Turner Director Oct 22, 2021
Eddie Joe Sullivan PRESIDENT, Director Aug 26, 2025
Jay S. Skyler Director Jul 15, 2024
Lucy To Chief Financial Officer Aug 26, 2025
Melissa Vera Ullerich Chief Communications Officer Mar 16, 2022
Jerry Lynn Pommer Chief Compliance Officer Mar 16, 2022
Hua Wu SVP Research & Product Dev. Oct 22, 2021
Russell Beyer Chief Financial Officer Mar 14, 2023
Scott Giberson Director Jul 15, 2024
David Charles Link Director Jul 15, 2024

Recent Insider Transactions by Companies or Individuals for SAB Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.